Related Experiment Video
Updated: Aug 30, 2025

Simple Continuous Glucose Monitoring in Freely Moving Mice
Published on: February 24, 2023
Lower Glycated Hemoglobin with Real-Time Continuous Glucose Monitoring Than with Intermittently Scanned Continuous
Lucie Radovnická1,2, Aneta Hásková3, Quoc Dat Do3
1First Faculty of Medicine, Charles University, Prague, Czech Republic.
Insights
Real-time continuous glucose monitoring (rtCGM) showed superior results compared to intermittently scanned continuous glucose monitoring (isCGM) in adults with type 1 diabetes. rtCGM led to lower HbA1c and reduced time spent in hypoglycemia.
Area of Science:
- Endocrinology
- Diabetes Management
- Medical Technology
Background:
- Type 1 diabetes (T1D) management requires effective glucose monitoring.
- Continuous glucose monitoring (CGM) systems offer real-time or intermittent data.
- Comparing the real-world efficacy of different CGM types is crucial for clinical guidance.
Purpose of the Study:
- To compare the efficacy of real-time continuous glucose monitoring (rtCGM) versus intermittently scanned continuous glucose monitoring (isCGM) in adults with T1D.
- To evaluate differences in glycated hemoglobin (HbA1c) levels and time spent in hypoglycemia as primary outcomes.
- To provide clinical insights into CGM device selection for T1D management.
Main Methods:
- A 12-month, real-world, nonrandomized study (CORRIDA LIFE) involving 191 adults with T1D.
- Participants were divided into rtCGM (Dexcom G5/G6) and isCGM (FreeStyle Libre 14-Day) groups.
- Primary endpoint was the difference in HbA1c at 12 months; secondary outcomes included time in hypoglycemia and time in target glucose range.
Main Results:
- rtCGM group achieved significantly lower HbA1c levels (7.1%) compared to the isCGM group (7.7%) after 12 months (P=0.0001).
- The rtCGM group spent less time in hypoglycemia (<70 mg/dL and <54 mg/dL) and more time in the target range (70-180 mg/dL) than the isCGM group.
- Significant differences were observed in time spent in hypoglycemia (P=0.003) and time in target range (P=0.0002).
Conclusions:
- rtCGM demonstrated superior glycemic control compared to isCGM in adults with T1D over 12 months.
- rtCGM use was associated with improved HbA1c, reduced hypoglycemia, and increased time in target glucose range.
- Findings support rtCGM as a more effective monitoring strategy for optimizing T1D management.
Abstract:
The aim was to compare the efficacy of real-time continuous glucose monitoring (rtCGM) and intermittently scanned continuous glucose monitoring (isCGM) focusing on glycated hemoglobin (HbA1c) as the primary endpoint. The CORRIDA LIFE was a 12-month, real-world, nonrandomized study that is part of the CORRIDA clinical trials program. The study compared rtCGM (Dexcom G5 or G6) and isCGM (FreeStyle Libre 14-Day; Abbott) in adults with type 1 diabetes (T1D). Only patients on multiple daily insulin injections or continuous subcutaneous insulin infusion with no automatic functions were included in this study. Primary outcome was the difference in HbA1c between study groups at 12 months. One hundred ninety-one adults with T1D (mean age 40 ± 13 years, HbA1c 8.1% ± 3.4% [65 ± 14 mmol/mol]) participated in this study; 81 patients initiated rtCGM and 110 initiated isCGM. After 12-months, HbA1c was significantly lower with rtCGM versus isCGM (7.1% ± 3.1% [54.1 ± 10.1 mmol/mol] vs. 7.7% ± 3.3% [61.2 ± 12.2 mmol/mol]), P = 0.0001. The percentage of time in hypoglycemia (<70 mg/dL [<3.9 mmol/L]) was lower among rtCGM vs. isCGM participants [4.3% ± 2.8% vs. 6.4% ± 5.3%], P = 0.003). Patients with rtCGM spent less time in clinically significant hypoglycemia (<54 mg/dL [<3.0 mmol/L]) (0.9% ± 1.0% vs. 2.3% ± 2.5%, P < 0.0001) and more time in target range (70-180 mg/dL [3.9-10 mmol/L]) than isCGM users (67.5% ± 14.8% vs. 57.8% ± 17.0%), P = 0.0002. rtCGM was superior to isCGM in HbA1c, hypoglycemia, and other glycemic outcomes. Our findings provide guidance to clinicians when discussing monitoring options with their patients. The study was registered at www.clinicaltrials.gov (NCT04759495).
Related Concept Videos
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Diabetes Mellitus: Type 2 and Gestational
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Hypoglycemia and Glucagon
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Glucose Absorption Into the Small Intestine

